EatingWell on MSN
The FDA just approved a new cholesterol pill—here’s what cardiologists want you to know
Not to be confused with statins, this new pill is the first of its kind.
FDA approves new kind of cholesterol pill
Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way from a statin to lower cholesterol.
FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients
The drug from Merck was OK'd for patients with artery-clogging cholesterol that persists even after taking statins.
Hosted on MSN
The FDA approved a first-of-its-kind pill that cuts stubborn cholesterol like the costly injections
Millions of adults whose cholesterol stays dangerously high despite taking statins now have a new option that does not require injections. The FDA approved Lipfendra, the brand name for enlicitide, as ...
FDA approves new cholesterol-lowering drug
The Food and Drug Administration has approved a new kind of drug to cut cholesterol. So we've called up NPR health correspondent Rob Stein to learn what it can do. Good morning, Rob. ROB STEIN, BYLINE ...
Scientific American
FDA approves cholesterol pill more powerful than statins
Most adults have levels of a dangerous type of cholesterol that are above 100, but this new drug can reduce levels to around 50 ...
Yahoo
FDA approves 1st-of-its-kind pill to reduce cholesterol
Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration (FDA) approved on Thursday a first-of-its-kind oral option that can lower "bad" LDL cholesterol ...
FDA Approves First-of-Its-Kind Cholesterol Pill, Ushering In New Wave of Treatment
Lipfendra, to be taken once a day, is designed to help lower cholesterol levels beyond what statins alone can achieve.
FDA approves first-of-its-kind cholesterol pill, on par with injectable drugs
Merck will market Lipfendra, which is a first-of-its-kind pill that can reduce cholesterol in a way that’s previously only ...
FDA approves first-of-its-kind cholesterol pill Lipfendra: What it will cost
The daily medication is expected to be list-priced at $10.50 per pill. Here's what to know about Merck's new cholesterol drug Lipfendra.
Los Angeles Times
FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients
This is read by an automated voice. Please report any issues or inconsistencies here. WASHINGTON — The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce ...
Yahoo
FDA approves first-of-its-kind cholesterol pill, on par with injectable drugs
Add Yahoo as a preferred source to see more of our stories on Google. Merck will market Lipfendra, which is a first-of-its-kind pill that can reduce cholesterol in a way that's previously only has ...